BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25975026)

  • 1. [Design, synthesis of novel N, N'-bis-(halogenophenyl)-4- methoxybenzene-1, 3-disulfonamides and evaluation of their anti-platelet aggregation activity].
    Li GA; Wang X; Meng X; Lin YB; Li X; Liu XJ
    Yao Xue Xue Bao; 2015 Feb; 50(2):185-90. PubMed ID: 25975026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and in vitro activities on anti-platelet aggregation of 4-methoxybenzene-1,3-isophthalamides.
    Liu XJ; Shi XX; Zhong YL; Liu N; Liu K
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6591-5. PubMed ID: 23010272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and the Evaluations in vitro Antiplatelet Aggregation Activities of 4-Ethoxyisophthalamides.
    Liu XJ; Shi TE; Wang X; Wei TT; Meng X
    Cardiovasc Hematol Agents Med Chem; 2015; 13(2):124-8. PubMed ID: 26695422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, in vitro cytotoxicity and biological evaluation of twenty novel 1,3-benzenedisulfonyl piperazines as antiplatelet agents.
    Liu XJ; Wang Y; Wang X; Zhang ZH
    Bioorg Med Chem; 2021 Sep; 46():116390. PubMed ID: 34500186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
    Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
    Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro anti-platelet aggregation activities of 2-methoxy-5-arylamido-N-(pyridin-3-yl-methyl)benzamides.
    Wang Y; Wang X; Chen X; Liu X
    Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800257. PubMed ID: 30500077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Design, synthesis and anti-platelet aggregation activities of ligustrazine-tetrahydroisoquinoline derivatives].
    Xie D; Zhang EL; Li JM; Wang J; He GW
    Yao Xue Xue Bao; 2015 Mar; 50(3):326-31. PubMed ID: 26118112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of 4-methoxy-3-arylamido-N-(substitutedphenyl)benzamide derivatives as potential antiplatelet agents.
    Liu X; Chen X; Qiu K; Zhang Z
    Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900231. PubMed ID: 31808975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel indole hydrazone derivatives and evaluation of their antiplatelet aggregation activity.
    Mashayekhi V; Haj Mohammad Ebrahim Tehrani K; Amidi S; Kobarfard F
    Chem Pharm Bull (Tokyo); 2013; 61(2):144-50. PubMed ID: 23154304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Design, synthesis, and biological evaluation of phenylpropenamides compounds as anti-platelet aggregation].
    Yang Y; Zuo J; Li JM; Ma XD; Zhang YC; Huang WJ
    Yao Xue Xue Bao; 2017 Jan; 52(1):120-5. PubMed ID: 29911807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
    Rehse K; Kotthaus J; Khadembashi L
    Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and inhibitory activities on platelet aggregation of some flavonoid analogues.
    Göker H; Tunçbilek M; Leoncini G; Buzzi E; Mazzei M; Rolland Y; Ertan R
    Arzneimittelforschung; 1995 Feb; 45(2):150-5. PubMed ID: 7710437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthesis of ferulic acid derivatives and their inhibitory effect on platelet aggregation].
    Li JM; Zhao YH; Zhong GC; Long ZJ; Zhou P; Yuan M
    Yao Xue Xue Bao; 2011 Mar; 46(3):305-10. PubMed ID: 21626785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis and Evaluation of Antiplatelet Aggregation Inhibitory Activities of the Analogs of Picotamide.
    Liu XJ
    Cardiovasc Hematol Agents Med Chem; 2015 Sep; ():. PubMed ID: 26362278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational Design and Synthesis of 1-(Arylideneamino)-4-aryl-1H-imidazole-2-amine Derivatives as Antiplatelet Agents.
    Amidi S; Esfahanizadeh M; Tabib K; Soleimani Z; Kobarfard F
    ChemMedChem; 2017 Jun; 12(12):962-971. PubMed ID: 28494138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis and Pharmacological Evaluation of Novel Piperlongumine derivatives as Potential Antiplatelet Aggregation Candidate.
    Wang Y; Wang J; Li J; Zhang Y; Huang W; Zuo J; Liu H; Xie D; Zhu P
    Chem Biol Drug Des; 2016 Jun; 87(6):833-40. PubMed ID: 26706668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis of thienopyridine derivatives and its anti-platelet activity in vivo].
    Zhou YS; Wang PB; Liu Y; Chen JF; Yue N; Liu DK
    Yao Xue Xue Bao; 2011 Jan; 46(1):70-4. PubMed ID: 21465811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation.
    Levent S; Çalışkan B; Çiftçi M; Özkan Y; Yenicesu I; Ünver H; Banoglu E
    Eur J Med Chem; 2013 Jun; 64():42-53. PubMed ID: 23639653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis of novel tryptophan derivatives for antiplatelet aggregation activity based on tripeptide pENW (pGlu-Asn-Trp).
    Xie Z; Feng S; Wang Y; Cao C; Huang J; Chen Y; Kong Y; Li Z
    Eur J Med Chem; 2015 Sep; 102():363-74. PubMed ID: 26298494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of 1,4-benzodioxine derivatives as novel platelet aggregation inhibitors.
    Xie Z; Zhao L; Ding X; Kong Y; Li Z
    Future Med Chem; 2018 Feb; 10(4):367-378. PubMed ID: 29380625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.